Precision Neuroscience’s Post

Precision BioMEMS / Precision Neuroscience are proud to be an official sponsor of the 46th Annual International Conference of the IEEE Engineering Medicine and Biology Society, taking place in Orlando, July 15 - 19, 2024. Precision is honored to support IEEE’s vision for the 2024 conference: “Technology and its promise for equity and access for well-health,” which will address the positive impacts that engineering can have on the whole  of society. The conference will cover a broad array of scientific tracks, from cutting-edge research in biomedical engineering to healthcare technology, in particular for women and children’s health. Stop by the Precision booth at IEEE EMBC 2024 to learn about Precision BioMEMS, our wholly owned and operated MEMS facility that produces our biocompatible microelectrode arrays and offers foundry services to pioneering third-party companies.

Join Precision Neuroscience’s Head of Microfabrication, Mark Hettick, today at the FLEX / SEMICON WEST 2024 Precision BioMEMS FLEXTalks presentation: “BioMEMS and FLEX Electronics: Medical FLEX Applications and a Foundry to Serve Them”. The topics among Mark’s talk will include the explosion of neurotech and the growing field of implantable MEMS, applications of flexible electronics, and new BioMEMS structures that are becoming increasingly relevant. Tuesday, July 9th, 2.20pm - 2.35pm at the Smart Stage FLEX Theater in the South Expo Hall (by the FLEX Exhibits) #SEMICONWest #SEMI_FLEX #BioMEMS #MicroFluidics #MedicalMEMS

Heading to SEMI Americas SEMICON WEST / FLEX 2024 conference this week in San Francisco? Stop by the Precision BioMEMS booth to learn firsthand about Precision's world class in-house manufacturing, foundry services, customized microfluidic platforms, and how Precision BioMEMS is shaping the future of Medical MEMS. Booth 1859 in the SEMICON WEST / FLEX South Expo Hall. #SEMICONWest #SEMI_FLEX

“Think about the idea of planting a device that can change the outcome of diseases like ALS, stroke, traumatic brain injury—so many things that we think are previously utterly untreatable...” - Kenneth L. Davis, MD, Executive Vice Chair, Board of Trustees, Mount Sinai Health System, introducing a panel at the Aspen Ideas Festival on the “Brain–Computer Interface Revolution.” Much of that revolution is taking place at Mount Sinai in New York City, where both Precision Neuroscience’s Benjamin Rapoport and Synchron’s Thomas Oxley are members of a groundbreaking neurosurgery department led by Dr. Joshua Bederson. Watch the video below for stories and insights from the front lines. #BrainComputerInterface #Neurosurgery #Neuroscience #AspenIdeas

Today at 4pm PST / 7pm EST Precision Neuroscience’s President and Chief Product Officer, Craig Mermel, will join other brain–computer interface industry leaders for an EverythingALS Expert Talk titled, "Implantable BCI Technology - The Road to Access." Register at the link below for what promises to be a fascinating discussion about the present and future of this fast-evolving technology, and what it could mean for people with ALS: https://lnkd.in/gCsi4irb #EndALS #EverythingALS #ALS #BrainComputerInterface #ALSExpertTalks Spencer Kellis Andreas Forsland Chris Ullrich Dr. Shelena Lalji

Precision Neuroscience is hiring! Working at Precision means collaborating with some of the world’s leading experts in fields ranging from brain surgery to software and mechanical engineering to circuit design and microfabrication—and beyond. Join us as we use cutting-edge science to improve brain health and restore connection and autonomy to people living with severe paralysis. See our open positions here: https://lnkd.in/eyY_Wf-N #Hiring #TechJobs #AIJobs #EngineeringJobs #BrainComputerInterface

"It used to be thought that you needed to put needle-like electrodes into the brain surface in order to listen to signals of adequate quality” to interface with computers, Dr. Benjamin Rapoport recently told Ars Technica. Today, Precision Neuroscience is proving that assumption wrong. Check out the full article about “the brain-chip maker taking the road less invasive," in which Beth Mole explains how Precision’s approach differs from competing BCI strategies.

Great report from Ashley Capoot at CNBC on a recent clinical case testing Precision Neuroscience’s brain-computer interface (BCI), which is designed to help patients with severe paralysis, restoring functions like speech and movement. Ashley was in the operating room at Mount Sinai Health System as surgeons implanted 4 Precision microelectrode arrays on a patient’s brain, streaming cortical data from over 4,000 channels—a new world record. The team was able to detect signals from the patient’s individual fingers. Her story breaks down what high resolution neural data like this could mean for medicine and vividly conveys what it feels like to be in the room as scientific history is being made. Give it a read: